Affinivax, Astellas’ pneumococcal vaccine wins breakthrough therapy status
15th July 2021 Uncategorised 0At the same time, Affinivax and Astellas revealed positive results from the Phase II trial of ASP3772
More: Affinivax, Astellas’ pneumococcal vaccine wins breakthrough therapy status
Source: News